FIELD: chemistry.;SUBSTANCE: invention relates to a method of obtaining 1'-arylhexahydro-1H-spiro [pyrimidine-5,2'-pyrrolizine]-2,4,6(1H,3H,5H)-trimones of general formula I which can be used as sedatives, anticonvulsant and cholinolytic agents. In the general formula I (a-m) , Ar=C6H5, R=H (Ia); Ar=4-CH3OC6H4, R=H (Ib); Ar=4-(CH3)2NC6H4, R=H (Ic); Ar=C6H5, R=3-C6H5OC6H4 (Id); Ar=4-CH3OC6H4, R=3-C6H5OC6H4 (Ie); Ar=4-(CH3)2NC6H4, R=3-C6H5OC6H4 (Ig); Ar=C6H5, R=2,4-Cl2C6H3 (Ih); Ar=4-CH3OC6H4 R=2,4-Cl2C6H3 (Ii); Ar=4-(CH3)2NC6H4, R=2,4-Cl2C6H3 (Ij); Ar=C6H5, R=3,4-(CH3O)2C6H3 (Ik); Ar=4-CH3OC6H4, R=3,4-(CH3O)2C6H3 (Il); Ar=4-(CH3)2NC6H4, R=3,4-(CH3O)2C6H3 (Im). The method for obtaining compounds of Ia-m consists of three-component heterocyclization by heating equimolar amounts of the corresponding 5-(arylmethylidene)-2,4,6-pyrimidine-2,4,6(1H,3H,5H)-trione of general formula II (a-c) , where Ar=C6H5 (IIa); Ar=4-CH3OC6H4 (IIb); Ar=4-(CH3)2NC6H4 (IIb); L-proline (III) and the corresponding aldehyde of general formula IV (a-d) RCHO, where R=H (IVa); R=3-C6H5OC6H4 (IVb); R=2,4-Cl2C6H3 (IVc); R=3,4-(CH3O)2C6H3 (IVd). Preferably the heterocyclization is carried out for 17 hours in dried toluene.;EFFECT: increasing the yield.;2 cl, 16 ex
展开▼
机译:技术领域本发明涉及一种获得通式的1'-芳基六氢-1H-螺环[嘧啶-5,2'-吡咯嗪] -2,4,6(1H,3H,5H)-三聚体的方法我可以用作镇静剂,抗惊厥药和胆汁溶解药。在通式I(am)中<图像文件=“ 00000008.JPG” he =“ 27” imgContent =“ undefined” imgFormat =“ JPEG” wi =“ 34” />,Ar = C 6 Sub > H 5 Sub>,R = H(Ia); Ar = 4-CH 3 Sub> OC 6 Sub> H 4 Sub>,R = H(Ib); Ar = 4-(CH 3 Sub>) 2 Sub> NC 6 Sub> H 4 Sub>,R = H(Ic); Ar = C 6 Sub> H 5 Sub>,R = 3-C 6 Sub> H 5 Sub> OC 6 Sub> H 4 Sub>(Id); Ar = 4-CH 3 Sub> OC 6 Sub> H 4 Sub>,R = 3-C 6 Sub> H 5 Sub> OC 6 Sub> H 4 Sub>(即); Ar = 4-(CH 3 Sub>) 2 Sub> NC 6 Sub> H 4 Sub>,R = 3-C 6 Sub> H 5 Sub> OC 6 Sub> H 4 Sub>(Ig); Ar = C 6 Sub> H 5 Sub>,R = 2,4-Cl 2 Sub> C 6 Sub> H 3 Sub>(Ih); Ar = 4-CH 3 Sub> OC 6 Sub> H 4 Sub> R = 2,4-Cl 2 Sub> C 6 Sub> H 3 Sub>(II); Ar = 4-(CH 3 Sub>) 2 Sub> NC 6 Sub> H 4 Sub>,R = 2,4-Cl < Sub> 2 Sub> C 6 Sub> H 3 Sub>(Ij); Ar = C 6 Sub> H 5 Sub>,R = 3,4-(CH 3 Sub> O) 2 Sub> C 6 Sub> H 3 Sub>(Ik); Ar = 4-CH 3 Sub> OC 6 Sub> H 4 Sub>,R = 3,4-(CH 3 Sub> O) 2 Sub> C 6 Sub> H 3 Sub>(II); Ar = 4-(CH 3 Sub>) 2 Sub> NC 6 Sub> H 4 Sub>,R = 3,4-(CH 3 Sub> O) 2 Sub> C 6 Sub> H 3 Sub>(Im)。获得Ia-m化合物的方法包括通过加热等摩尔量的相应的5-(芳基亚甲基)-2,4,6-嘧啶-2,4,6(1H,3H,5H)-三酮进行三组分杂环化公式II(ac)的<图像文件=“ 00000009.JPG” he =“ 25” imgContent =“ undefined” imgFormat =“ JPEG” wi =“ 38” />,其中Ar = C 6 Sub > H 5 Sub>(IIa); Ar = 4-CH 3 Sub> OC 6 Sub> H 4 Sub>(IIb); Ar = 4-(CH 3 Sub>) 2 Sub> NC 6 Sub> H 4 Sub>(IIb); L-脯氨酸(III)和相应的通式IV(a-d)的醛RCHO,其中R = H(IVa); R = 3-C 6 Sub> H 5 Sub> OC 6 Sub> H 4 Sub>(IVb); R = 2,4-Cl 2 Sub> C 6 Sub> H 3 Sub>(IVc); R = 3,4-(CH 3 Sub> O) 2 Sub> C 6 Sub> H 3 Sub>(IVd)。杂环化反应最好在干燥的甲苯中进行17小时。效果:提高收率; 2 cl,16 ex
展开▼